September 10, 2019
Authored and Edited by Victor H. Feng; Samhitha M. Medatia; Elizabeth D. Ferrill
In Guangdong Alison Hi-Tech Co. v. International Trade Commission, No. 2018-2042 (Fed. Cir. Aug. 27, 2019), the Federal Circuit affirmed the ITC’s findings that the claims of U.S. Patent No. 7,078,359 were not invalid under 35 U.S.C. § 112 and § 102.
The ’359 patent is directed to an improvement in aerogel composite products and includes a claim directed to, among other things, “lofty . . . batting.” Aspen Aerogels, Inc., filed an ITC complaint alleging that Alison imported aerogel insulation materials that infringed the ‘359 patent. Despite Alison’s challenge that the term “lofty . . . batting” was indefinite, the ITC found that the ’359 patent was not invalid and entered an exclusion order barring importation. Alison appealed.
The Federal Circuit affirmed. The court found that the written description of the ’359 patent provided express definition, functional characteristics, and specific examples to the claim term “lofty . . . batting.” As a result, the claim term was not indefinite. The Federal Circuit also found that the ITC’s conclusion that the ’359 patent was not anticipated was supported by substantial evidence. Accordingly, the Federal Circuit affirmed the ITC.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Seminar
The Augmented Practice 2026: Balancing AI Opportunity, Governance, and Risk
November 5, 2026
San Francisco
Articles
EPR Academy, Part 5 of 6: Special Considerations for Third-Party Requesters
October 14, 2026
Conference
2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada
October 14-16, 2026
New York
Webinar
2026 Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches
October 14, 2026
Webinar
Articles
Who Is a “Consumer?” The Supreme Court Takes Up the Video Privacy Protection Act
October 12, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.